60 Results for "

GlyT

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "GlyT" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-18638
CAS No.: 30675-13-9
Synonyms: 4,5,6,7-Tetrachloroindan-1,3-dione
Target:  

Deubiquitinase

Research Areas:  

Neurological Disease

TCID (4,5,6,7-Tetrachloroindan-1,3-dione) is a potent and selective neuronal ubiquitin C-terminal hydrolase (UCH-L3) inhibitor with an IC50 of 0.6 μM . TCID diminishes glycine transporter GlyT2 ubiquitination in brainstem and spinal cord primary neurons .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101037
CAS No.: 107-97-1
Purity:  ≥98.0%
Synonyms: N-Methylglycine; Sarcosin
Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-138935
CAS No.: 1421936-85-7
Purity:  99.97%
Synonyms: BI-425809
Target:  

GlyT

Research Areas:  

Neurological Disease

Iclepertin (BI-425809) is a potent, selective and orally active glycine transporter 1 (GlyT1) inhibitor. Iclepertin is inactive against GlyT2. Iclepertin can be used for Alzheimer disease and schizophrenia research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10809
CAS No.: 845614-11-1
Purity:  99.90%
Synonyms: RG1678; RO4917838
Target:  

GlyT

Research Areas:  

Neurological Disease

Bitopertin is a potent, noncompetitive glycine reuptake inhibitor, inhibits glycine uptake at human GlyT1 with a concentration exhibiting IC50 of 25 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113202
CAS No.: 25597-09-5
Purity:  99.91%
Stearoylcarnitine, a fatty ester lipid molecule, is an endogenous metabolite. Stearoylcarnitine can be used as PKC inhibitor. Stearoylcarnitine accumulates in β cells, leading to arrest of insulin synthesis and energy deficiency in type 2 diabetes mouse. Stearoylcarnitine inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbits plasma. Stearoylcarnitine acts as a metabolomics biomarker for Parkinson’s disease. Stearoylcarnitine is a less potent inhibitor of GlyT2 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103332
CAS No.: 179113-91-8
Purity:  98.90%
Synonyms: NA-Gly
N-Arachidonylglycine (NA-Gly), a carboxylic analog of the endocannabinoid anandamide (AEA), is a GPR18 agonist (EC50 = 44.5 nM). Unlike AEA, N-Arachidonylglycine has no activity at either CB1 or CB2 receptors. N-Arachidonylglycine inhibits GLYT2 (IC50 = 5.1 μM). N-Arachidonylglycine also is an effective activator of endometrial cell migration .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130466
CAS No.: 32350-57-5
Purity:  99.90%
Stearoyl-L-carnitine chloride is an endogenous long-chain acylcarnitine. Stearoyl-L-carnitine chloride is a less potent inhibitor of GlyT2. Stearoyl-L-carnitine chloride inhibits glycine responses by 16.8% at concentrations up 3 μM .
loading...
    loading...
Cat. No.: HY-101037S1
CAS No.: 118685-91-9
Purity:  99.05%
Synonyms: N-Methylglycine-d3; Sarcosin-d3
Sarcosine-d3 is the deuterium labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .
loading...
    loading...
Cat. No.: HY-109067A
CAS No.: 1440796-75-7
Purity:  99.62%
Synonyms: VVZ-149 hydrochloride
Research Areas:  

Neurological Disease

Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain .
loading...
    loading...
Cat. No.: HY-10716A
CAS No.: 1173239-39-8
Purity:  98.40%
Target:  

GlyT

Research Areas:  

Neurological Disease

PF-03463275 is a centrally penetrant, orally available, selective, and competitive GlyT1 (glycine transporter-1) reversible inhibitor, with a Ki of 11.6 nM. PF-03463275 has the potential for Schizophrenia research .
loading...
    loading...
Cat. No.: HY-112432
CAS No.: 1820934-93-7
Purity:  98.59%
Target:  

GlyT

Research Areas:  

Neurological Disease

GlyT1 Inhibitor 1 is a potent and selective GlyT1 inhibitor with an IC50 of 38 nM for rGlyT1 . Antipsychotic activity .
loading...
    loading...
Cat. No.: HY-111029A
Purity:  99.83%
Target:  

GlyT

Research Areas:  

Others

ALX-1393 TFA, a selective GlyT2 inhibitor, has an antinociceptive effect on thermal, mechanical, and chemical stimulations in a rat acute pain model .
loading...
    loading...
Cat. No.: HY-10711A
CAS No.: 200006-08-2
Purity:  98.20%
Synonyms: (R)-NFPS hydrochloride
Target:  

GlyT

Research Areas:  

Neurological Disease

ALX-5407 ((R)-NFPS) hydrochloride is a selective and orally active glycine transporter GlyT1 inhibitor with an IC50 value of 3 nM. ALX-5407 hydrochloride can be used the research of N-methyl-D-aspartate-receptor function and schizophrenia .
loading...
    loading...
Cat. No.: HY-130466S
CAS No.: 2245711-27-5
Purity:  99.80%
Stearoyl-L-carnitine-d3 (chloride) is the deuterium labeled Stearoyl-L-carnitine chloride. Stearoyl-L-carnitine chloride is an endogenous long-chain acylcarnitine. Stearoyl-L-carnitine chloride is a less potent inhibitor of GlyT2. Stearoyl-L-carnitine chloride inhibits glycine responses by 16.8% at concentrations up 3 μM .
loading...
    loading...
Cat. No.: HY-101037R
CAS No.: 107-97-1
Synonyms: N-Methylglycine (Standard); Sarcosin (Standard)
Sarcosine (Standard) is the analytical standard of Sarcosine. This product is intended for research and analytical applications. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .
loading...
    loading...
Cat. No.: HY-111029
CAS No.: 949164-09-4
Target:  

GlyT

Research Areas:  

Neurological Disease

ALX-1393, a selective GlyT2 inhibitor, has an antinociceptive effect on thermal, mechanical, and chemical stimulations in a rat acute pain model .
loading...
    loading...
Cat. No.: HY-107527
CAS No.: 495076-64-7
Purity:  99.93%
Target:  

GlyT

Research Areas:  

Neurological Disease

Org 25543 hydrochloride is a selective and irreversible GlyT2 inhibitor (IC50: 16 nM). Org 25543 hydrochloride has analgesia effect. Org 25543 hydrochloride ameliorates mechanical allodynia after partial sciatic nerve ligation injury in mice .
loading...
    loading...
Cat. No.: HY-10715
CAS No.: 615571-23-8
Purity:  99.82%
Target:  

GlyT

Research Areas:  

Neurological Disease

SSR504734 is an orally active, selective and reversible inhibitor of human, rat, and mouse GlyT1 (IC50=18, 15, and 38 nM, respectively). SSR504734 shows anti-schizophrenia, anti-anxiety and anti-depression activities .
loading...
    loading...
Cat. No.: HY-101037S
Purity:  ≥99.0%
Synonyms: N-Methylglycine-15N; Sarcosin-15N
Sarcosine- 15N is the 15N-labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .
loading...
    loading...
Cat. No.: HY-109067
CAS No.: 1441000-45-8
Synonyms: VVZ-149
Research Areas:  

Neurological Disease

Opiranserin (VVZ-149), a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin is development as an injectable agent for the treatment of postoperative pain .
loading...
    loading...